Diazoxide is a benzothiadiazine derivative and potassium channel activator primarily used to manage hypoglycemia resulting from insulinoma, as well as to treat hypertensive emergencies. Laboratories working… Read more



![Chemical structure of 3-Benzoyl-6-chloro-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F13659-96-6-3-Benzoyl-6-chloro-4H-benzoe124thiadiazine-7-sulfonamide-11-dioxide.png&w=3840&q=75)

![Chemical structure of 6-Chloro-3-styryl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F93899-47-9-6-Chloro-3-styryl-34-dihydro-2H-benzoe124thiadiazine-7-sulfonamide-11-dioxide.png&w=3840&q=75)

![Chemical structure of 7-Chloro-2H-benzo[e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5800-59-9-7-Chloro-2H-benzoe124thiadiazin-34H-one-11-dioxide.png&w=3840&q=75)
![Chemical structure of 7-Chloro-4H-benzo[e][1,2,4]thiadiazine-3-carboxylic acid 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F51264-26-7-7-Chloro-4H-benzoe124thiadiazine-3-carboxylic-acid-11-dioxide.png&w=3840&q=75)
















Diazoxide is a benzothiadiazine derivative and potassium channel activator primarily used to manage hypoglycemia resulting from insulinoma, as well as to treat hypertensive emergencies. Laboratories working with this medication require high-quality Diazoxide reference standards to ensure rigorous quality control. This category includes the active pharmaceutical ingredient alongside a comprehensive range of pharmacopeial and non-pharmacopeial impurities, including degradation products formed via hydrolysis, oxidation, or photolysis. Additionally, stable isotope labelled compounds are provided to support precise analytical testing, such as serving as internal standards for mass spectrometry. These materials are essential for effective impurity profiling and method validation, allowing researchers to accurately assess drug stability and safety in compliance with regulatory guidelines. By providing characterization of structurally related analogs and degradation pathways, these reference materials facilitate consistent results in analytical method development and long-term stability studies.